Parallel Bio

Parallel Bio is a biotechnology company based in Cambridge, Massachusetts, pioneering a new approach to drug discovery by using human immune organoids and artificial intelligence. Their platform replicates the human immune system "in a dish," enabling the development and testing of immunotherapies and drugs directly on human models rather than relying on animal testing. This method addresses the inefficiencies and ethical concerns of traditional pharmaceutical development, where animal models often fail to predict human outcomes, leading to high costs, long timelines, and a high failure rate for new drugs. By leveraging organoids and AI, Parallel Bio can rapidly generate novel immune data, drive AI-powered drug discovery, and verify drug candidates in vitro, significantly reducing risk and accelerating the path to market for new therapies.

Working at Parallel Bio offers the opportunity to be at the forefront of transforming medicine, with a mission-driven team focused on making drug development faster, cheaper, and more ethical. Employees contribute to a technology that not only replaces animal testing but also increases the likelihood that new therapies will be effective and safe for diverse human populations. The company’s innovative culture is supported by recent funding and partnerships with leading pharma and biotech organizations, providing a dynamic environment for scientists, engineers, and innovators passionate about advancing human health and making a global impact.